Elkins David V's Form 4 filing
Bristol Myers Squibb Co (BMY) · filed Apr 2, 2026
- Accession no.
- 0001451604-26-000004
- Filed
- Apr 2, 2026
- Trade date
- Apr 1, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.85M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Elkins David VCIK 0001451604 | Officer (EVP, Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock, $0.10 par value | SSaleDisposed | −25,519 | $61.60 | −$1,571,970.4 | 163,729 | Direct | |
| Apr 1, 2026 | Common Stock, $0.10 par value | SSaleDisposed | −4,481 | $62.05 | −$278,046.05 | 159,248 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.